IL-10 and TGF-β2 are overexpressed in tumor spheres cultured from human gliomas

Molecular Biology Reports

Volumn 38, Issue 5, 2011, Pages 3585-3591

  Qiu, Bo ^a   Zhang, Dongyong ^a   Wang, Chao ^a   Tao, Jun ^a   Tie, Xinxin ^a   Qiao, Ying ^a   Xu, Ke ^a   Wang, Yunjie ^a   Wu, Anhua ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

CD133; Glioma; IL 10; Primary cultured glioma cells (PCGCs); TGF 2; Tumor sphere cells (TSCs)

Indexed keywords

INTERLEUKIN 10; MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA2;

ANAPLASTIC OLIGODENDROGLIOMA; ARTICLE; CANCER GRADING; CANCER STEM CELL; CARCINOGENESIS; CELL CLONE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; GENE EXPRESSION; GLIOBLASTOMA; GLIOMA; GLIOMA CELL; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; OLIGODENDROGLIOMA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR CELL; TUMOR SPHERE CELL;

ANTIGENS, CD; BIOLOGICAL MARKERS; GLIOMA; GLYCOPROTEINS; HUMANS; INTERLEUKIN-10; NEOPLASTIC STEM CELLS; NEUROGLIA; NEURONS; PEPTIDES; TRANSFORMING GROWTH FACTOR BETA2; TUMOR CELLS, CULTURED;

EID: 79960790320     PISSN: 03014851     EISSN: 15734978     Source Type: Journal    
DOI: 10.1007/s11033-010-0469-4     Document Type: Article

References (24)

1. Reardon DA, Rich JN, Friedman HS, Bigner DD (2006) Recent advances in the treatment of malignant astrocytoma. J Clin Oncol 24:1253-1265 (Pubitemid 46622028)
2. DeAngelis LM (2001) Brain tumors. N Engl J Med 344:114-123 (Pubitemid 32052502)
3. Grauer O, Poschl P, Lohmeier A, Adema GJ, Bogdahn U (2007) Toll-like receptor triggered dendritic cell maturation and IL-12 secretion are necessary to overcome t-cell inhibition by gliomaassociated TGF-beta2. J Neurooncol 82:151-161 (Pubitemid 46431857)
4. Wick W, Naumann U, Weller M (2006) Transforming growth factor-beta: a molecular target for the future therapy of glioblastoma. Curr Pharm Des 12:341-349
5. Singh SK, Clarke ID, Terasaki M et al (2003) Identification of a cancer stem cell in human brain tumors. Cancer Res 63:5821-5828 (Pubitemid 37187480)
6. Singh SK, Hawkins C, Clarke ID et al (2004) Identification of human brain tumour initiating cells. Nature 432:396-401 (Pubitemid 39551674)
7. Galli R, Binda E, Orfanelli U et al (2004) Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res 64:7011-7021 (Pubitemid 39331011)
8. Yuan X, Curtin J, XiongYet al (2004) Isolation of cancer stem cells from adult glioblastoma multiforme. Oncogene 23:9392-9400 (Pubitemid 40069671)
9. Wu A, Wiesner S, Xiao J et al (2007) Expression of MHC I and NK ligands on human CD133? glioma cells: possible targets of immunotherapy. J Neurooncol 83:121-131
10. Janelidze S, Bexell D, Badn W et al (2009) Immunizations with ifngamma secreting tumor cells can eliminate fully established and invasive rat gliomas. J Immunother 32:593-601
11. Wu A, Oh S, Gharagozlou S et al (2007) In vivo vaccination with tumor cell lysate plus cpg oligodeoxynucleotides eradicates murine glioblastoma. J Immunother 30:789-797 (Pubitemid 350295357)
12. Izumoto S, Tsuboi A, Oka Y et al (2008) Phase II clinical trial of wilms tumor 1 peptide vaccination for patients with recurrent glioblastoma multiforme. J Neurosurg 108:963-971 (Pubitemid 351656845)
13. Yamanaka R, Homma J, Yajima N et al (2005) Clinical evaluation of dendritic cell vaccination for patients with recurrent glioma: results of a clinical phase I/II trial. Clin Cancer Res 11:4160-4167 (Pubitemid 40791581)
14. Grauer OM, Wesseling P, Adema GJ (2009) Immunotherapy of diffuse gliomas: biological background, current status and future developments. Brain Pathol 19:674-693
15. Parney IF, Hao C, Petruk KC (2000) Glioma immunology and immunotherapy. Neurosurgery 46:778-791 discussion 791-772
16. Hishii M, Nitta T, Ishida H et al (1995) Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro. Neurosurgery 37:1160-1166; discussion 1166-1167
17. Constam DB, Philipp J, Malipiero UV, ten Dijke P, Schachner M, Fontana A (1992) Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia. J Immunol 148:1404-1410
18. Alcocer-Gonzalez JM, Berumen J, Tamez-Guerra R et al (2006) In vivo expression of immunosuppressive cytokines in human papillomavirus-transformed cervical cancer cells. Viral Immunol 19:481-491 (Pubitemid 44735060)
19. Beckebaum S, Zhang X, Chen X et al (2004) Increased levels of interleukin-10 in serum from patients with hepatocellular carcinoma correlate with profound numerical deficiencies and immature phenotype of circulating dendritic cell subsets. Clin Cancer Res 10:7260-7269 (Pubitemid 39487713)
20. Huettner C, Paulus W, Roggendorf W (1995) Messenger rna expression of the immunosuppressive cytokine IL-10 in human gliomas. Am J Pathol 146:317-322
21. Kjellman C, Olofsson SP, Hansson O et al (2000) Expression of TGF-beta isoforms, TGF-beta receptors, and smad molecules at different stages of human glioma. Int J Cancer 89:251-258 (Pubitemid 30430741)
22. von Bernstorff W, Voss M, Freichel S et al (2001) Systemic and local immunosuppression in pancreatic cancer patients. Clin Cancer Res 7:925s-932s (Pubitemid 33600947)
23. Tsamandas AC, Kardamakis D, Ravazoula P et al (2004) The potential role of TGFbeta1, TGFbeta2 and TGFbeta3 protein expression in colorectal carcinomas. Correlation with classic histopathologic factors and patient survival. Strahlenther Onkol 180:201-208 (Pubitemid 38461544)
24. Penuelas S, Anido J, Prieto-Sanchez RM et al (2009) TGF-beta increases glioma-initiating cell self-renewal through the induction of LIF in human glioblastoma. Cancer Cell 15:315-327